Mohammad Hassanipour

Title: Mohammad Hassanipour: Innovator in Plasmid-Liposome Technology

Introduction

Mohammad Hassanipour is a notable inventor based in Vallejo, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of plasmid-liposome complexes for transfection. With a total of 2 patents, his work is paving the way for advancements in genetic engineering and therapeutic applications.

Latest Patents

Hassanipour's latest patents include a composition for transfection that features a plasmid-liposome complex. This innovative composition consists of plasmid molecules condensed with a polycationic condensing agent and cationic liposomes. Additionally, he has developed an improved method for preparing these plasmid-liposome complexes for in vivo transfection. This improvement involves selecting a condensing agent to condense the plasmid prior to contact with the liposomes, as well as choosing an appropriate working medium and a specific ratio of liposome lipid to plasmid.

Career Highlights

Hassanipour is currently associated with Sequus Pharmaceuticals, Inc., where he continues to explore and expand the applications of his inventions. His work is instrumental in enhancing the efficiency of gene delivery systems, which are crucial for various therapeutic interventions.

Collaborations

Some of his notable coworkers include Shi Kun Huang and Edwin Kiyoshi Oto. Their collaborative efforts contribute to the innovative environment at Sequus Pharmaceuticals, Inc.

Conclusion

In summary, Mohammad Hassanipour is a prominent inventor whose work in plasmid-liposome technology is making significant strides in biotechnology. His patents and ongoing research are vital for the future of genetic therapies and transfection methods.